Dicerna Pharmaceuticals Inc.

(DRNA) Trade

By |

Profile

Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.

Contact Information

Website: www.dicerna.com
Main Phone: +1 617 621-8097
Address: 87 Cambridgepark Drive
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02140

Issuer Information

Exchange: NGS
CEO: Douglas M. Fambrough
Employees: 44
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 12.50 $ -0.64 (-4.87%)
Last Price 12.50 Change $ -0.64 Change % -4.87 Tick N/A
Bid 9.10 Bid Size 200.00 Ask 19.87 Ask Size 1,500.00
Open 13.18 High 13.45 Low 12.39 Prev Close 13.14
Last Trade Volume 348,349 52 Wk Hi 15.80 52 Wk Low 2.69
Market Cap 660.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,821,624.00 EPS (TTM) -3.27 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 21 38
Number of Buys 3 12
Number of Sells 18 26
Net Activity -558764 12134623
Last 10 Buys Shares
Adam Koppel 1,000
Douglas M. Fambrough 1,000
Douglas M. Fambrough 1,000
James B. Weissman 1,000
James B. Weissman 1,000
James B. Weissman 1,000
Stephen J. Hoffman 1,000
Douglas M. Fambrough 1,000
James B. Weissman 1,000
Last 10 Sell Shares
James B. Weissman 1,000
Bob Brown 1,000
James B. Weissman 1,000
James B. Weissman 1,000
Dennis H. Langer 1,000
John G. Freund 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 14 14 14 14
Standard Deviation 2.61 2.61 2.61 2.61
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 3 3 3 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.86 1.86 1.33